ArticleMaterials today. Bio2026
Immuno-engineered conductive hydrogels: Bridging neural signaling and microenvironmental remodeling for neural repair.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nervous system injuries and diseases present formidable regenerative challenges, largely due to hostile inflammatory microenvironments that impede endogenous repair mechanisms. Conductive nanocomposite hydrogels have emerged as a transformative class of immuno-engineered biomaterials designed to actively overcome these barriers. Beyond providing electroactive scaffolds to restore neural signaling, these advanced platforms integrate functional nanomaterials (e.g., carbon-based, MXene, and conductive polymers) within biocompatible polymer networks to facilitate targeted immunomodulation. Their core scientific significance lies in their synergistic capacity to simultaneously scavenge pathological reactive oxygen species (ROS) and steer macrophage polarization towards a pro-regenerative phenotype, thereby reprogramming the inhibitory injury niche into a permissive, pro-healing milieu. This review systematically elucidates the design principles spanning crosslinking strategies to nanomaterial selection that underpin these dual functions. We critically summarize recent breakthroughs in applying these multifunctional hydrogels to treat spinal cord injury, traumatic brain injury, stroke, and peripheral nerve defects, where they demonstrate enhanced functional recovery. By bridging the fields of conductive biomaterials and immunomodulation, this work not only surveys the state-of-the-art but also provides a unified framework for developing next-generation therapeutic platforms that couple bioelectronic cues with precise immune modulation, offering a novel paradigm for neural regeneration medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.